Antigen Crosspresentation by Human Plasmacytoid Dendritic Cells

Immunity

Volumn 27, Issue 3, 2007, Pages 481-492

  Hoeffel, Guillaume ^a,b,c,d   Ripoche, Anne Claire ^a,b,c,d   Matheoud, Diana ^a,b,c,d   Nascimbeni, Michelina ^a,b,c,d   Escriou, Nicolas ^e   Lebon, Pierre ^d   Heshmati, Farhad ^f   Guillet, Jean Gérard ^a,b,c,d   Gannagé, Monique ^d,g   Caillat Zucman, Sophie ^d,g   Casartelli, Nicoletta ^c   Schwartz, Olivier ^c   De la Salle, Henri ^b   Hanau, Daniel ^b   Hosmalin, Anne ^a,b,c,d   Marañón, Concepción ^a,b,c,d  

^a INSTITUT COCHIN   (France)

^b INSERM   (France)

^c CNRS   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e INSTITUT PASTEUR   (France)

^f Hôpital Cochin ^*  (France)

^g HÔPITAL SAINT VINCENT DE PAUL   (France)

Author keywords

CELLIMMUNO; MICROBIO

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; LIPOPEPTIDE;

ALLERGY; ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL SPECIFICITY; DENDRITIC CELL; ENDOSOME; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INFECTION; INFLUENZA; INTERNALIZATION; NONHUMAN; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTOSIS; PRIORITY JOURNAL;

AIDS VACCINES; ANTIGEN PRESENTATION; APOPTOSIS; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DENDRITIC CELLS; HIV; HIV ANTIGENS; HUMANS; LEUKOCYTES; LIPOPROTEINS; LYMPHOCYTE ACTIVATION; MICROSCOPY, CONFOCAL; TRANSFECTION;

EID: 34548674705     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2007.07.021     Document Type: Article

References (62)

1. Albert M.L. Death-defying immunity: do apoptotic cells influence antigen processing and presentation?. Nat. Rev. Immunol. 4 (2004) 223-231
2. + T cells. Nat. Immunol. 2 (2001) 1010-1017
3. Andrieu M., Desoutter J.F., Loing E., Gaston J., Hanau D., Guillet J.G., and Hosmalin A. Two HIV vaccinal lipopeptides follow different cross-presentation pathways in human dendritic cells. J. Virol. 77 (2003) 1564-1570
4. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
5. Bave U., Magnusson M., Eloranta M.L., Perers A., Alm G.V., and Ronnblom L. Fc gamma RIIa is expressed on natural IFN-alpha-producing cells (plasmacytoid dendritic cells) and is required for the IFN-alpha production induced by apoptotic cells combined with lupus IgG. J. Immunol. 171 (2003) 3296-3302
6. Beignon A.S., McKenna K., Skoberne M., Manches O., Dasilva I., Kavanagh D.G., Larsson M., Gorelick R.J., Lifson J.D., and Bhardwaj N. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor- viral RNA interactions. J. Clin. Invest. 115 (2005) 3265-3275
7. + T cells after FcgammaRII-mediated uptake. J. Exp. Med. 203 (2006) 1629-1635
8. Bevan M.J. Minor H antigens introduced on H-2 different stimulating cells cross-react at the cytotoxic T cell level during in vivo priming. J. Immunol. 117 (1976) 2233-2238
9. Blander J.M., and Medzhitov R. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 440 (2006) 808-812
10. Blasius A.L., and Colonna M. Sampling and signaling in plasmacytoid dendritic cells: the potential roles of Siglec-H. Trends Immunol. 27 (2006) 255-260
11. Boasso A., Vaccari M., Nilsson J., Shearer G.M., Andersson J., Cecchinato V., Chougnet C., and Franchini G. Do regulatory T-cells play a role in AIDS pathogenesis?. AIDS Rev. 8 (2006) 141-147
12. Brimnes M.K., Bonifaz L., Steinman R.M., and Moran T.M. Influenza virus-induced dendritic cell maturation is associated with the induction of strong T cell immunity to a coadministered, normally nonimmunogenic protein. J. Exp. Med. 198 (2003) 133-144
13. Cella M., Facchetti F., Lanzavecchia A., and Colonna M. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat. Immunol. 1 (2000) 305-310
14. + T cells by viral and tumor antigens is a robust phenomenon. Eur. J. Immunol. 34 (2004) 194-199
15. Cresswell P., Ackerman A.L., Giodini A., Peaper D.R., and Wearsch P.A. Mechanisms of MHC class I-restricted antigen processing and cross-presentation. Immunol. Rev. 207 (2005) 145-157
16. de Heer H.J., Hammad H., Soullie T., Hijdra D., Vos N., Willart M.A., Hoogsteden H.C., and Lambrecht B.N. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J. Exp. Med. 200 (2004) 89-98
17. Durier C., Launay O., Meiffredy V., Saidi Y., Salmon D., Levy Y., Guillet J.G., Pialoux G., and Aboulker J.P. Clinical safety of HIV lipopeptides used as vaccines in healthy volunteers and HIV-infected adults. AIDS 20 (2006) 1039-1049
18. Dzionek A., Sohma Y., Nagafune J., Cella M., Colonna M., Facchetti F., Gunther G., Johnston I., Lanzavecchia A., Nagasaka T., et al. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J. Exp. Med. 194 (2001) 1823-1834
19. + T cells: a new role for plasmacytoid dendritic cells in adaptive immunity. Blood 101 (2003) 3520-3526
20. Fonteneau J.F., Larsson M., Beignon A.S., McKenna K., Dasilva I., Amara A., Liu Y.J., Lifson J.D., Littman D.R., and Bhardwaj N. Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells. J. Virol. 78 (2004) 5223-5232
21. Gahery H., Choppin J., Bourgault I., Fischer E., Maillere B., and Guillet J.G. HIV preventive vaccine research at the ANRS: the lipopeptide vaccine approach. Therapie 60 (2005) 243-248
22. Gilliet M., and Liu Y.J. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J. Exp. Med. 195 (2002) 695-704
23. Grouard G., Rissoan M.-C., Filgueira L., Durand I., Banchereau J., and Liu Y.-J. The enigmatic plasmacytoid T cells develop into dendritic cells with Interleukin 3 and CD40-ligand. J. Exp. Med. 185 (1997) 1101-1111
24. Guermonprez P., Valladeau J., Zitvogel L., Thery C., and Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20 (2002) 621-667
25. Guermonprez P., Saveanu L., Kleijmeer M., Davoust J., Van Endert P., and Amigorena S. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature 425 (2003) 397-402
26. Guiducci C., Ott G., Chan J.H., Damon E., Calacsan C., Matray T., Lee K.D., Coffman R.L., and Barrat F.J. Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation. J. Exp. Med. 203 (2006) 1999-2008
27. Heath W.R., Belz G.T., Behrens G.M., Smith C.M., Forehan S.P., Parish I.A., Davey G.M., Wilson N.S., Carbone F.R., and Villadangos J.A. Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol. Rev. 199 (2004) 9-26
28. Honda K., Ohba Y., Yanai H., Negishi H., Mizutani T., Takaoka A., Taya C., and Taniguchi T. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 434 (2005) 1035-1040
29. Ito T., Kanzler H., Duramad O., Cao W., and Liu Y.J. Specialization, kinetics, and repertoire of type 1 interferon responses by human plasmacytoid predendritic cells. Blood 107 (2006) 2423-2431
30. Kadowaki N., Antonenko S., Lau J., and Liu Y. Natural interferon α/β-producing cells link innate and adaptive immunity. J. Exp. Med. 192 (2000) 219-225
31. Kapsenberg M.L. Dendritic-cell control of pathogen-driven T-cell polarization. Nat. Rev. Immunol. 3 (2003) 984-993
32. + cytotoxic regulatory T cells. Blood 107 (2006) 1031-1038
33. Lore K., Betts M.R., Brenchley J.M., Kuruppu J., Khojasteh S., Perfetto S., Roederer M., Seder R.A., and Koup R.A. Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses. J. Immunol. 171 (2003) 4320-4328
34. + T cells. J. Exp. Med. 201 (2005) 2023-2033
35. + T lymphocytes. Proc. Natl. Acad. Sci. USA 101 (2004) 6092-6097
36. Means T.K., Latz E., Hayashi F., Murali M.R., Golenbock D.T., and Luster A.D. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J. Clin. Invest. 115 (2005) 407-417
37. + regulatory T cells. J. Immunol. 173 (2004) 4433-4442
38. Moser M. Dendritic cells in immunity and tolerance-do they display opposite functions?. Immunity 19 (2003) 5-8
39. Napolitani G., Rinaldi A., Bertoni F., Sallusto F., and Lanzavecchia A. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat. Immunol. 6 (2005) 769-776
40. O'Garra A., and Vieira P. Regulatory T cells and mechanisms of immune system control. Nat. Med. 10 (2004) 801-805
41. Ochando J.C., Homma C., Yang Y., Hidalgo A., Garin A., Tacke F., Angeli V., Li Y., Boros P., Ding Y., et al. Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat. Immunol. 7 (2006) 652-662
42. Patterson S., Rae A., Hockey N., Gilmour J., and Gotch F. Plasmacytoid dendritic cells are highly susceptible to human immunodeficiency virus type 1 infection and release infectious virus. J. Virol. 75 (2001) 6710-6713
43. Pichlmair A., Diebold S.S., Gschmeissner S., Takeuchi Y., Ikeda Y., Collins M.K., and Reis e Sousa C. Tubulovesicular structures within vesicular stomatitis virus G protein-pseudotyped lentiviral vector preparations carry DNA and stimulate antiviral responses via Toll-like receptor 9. J. Virol. 81 (2007) 539-547
44. Reis e Sousa C. Dendritic cells in a mature age. Nat. Rev. Immunol. 6 (2006) 476-483
45. Rock K.L., and Shen L. Cross-presentation: underlying mechanisms and role in immune surveillance. Immunol. Rev. 207 (2005) 166-183
46. Salio M., Cella M., Vermi W., Facchetti F., Palmowski M.J., Smith C.L., Shepherd D., Colonna M., and Cerundolo V. Plasmacytoid dendritic cells prime IFN-gamma-secreting melanoma-specific CD8 lymphocytes and are found in primary melanoma lesions. Eur. J. Immunol. 33 (2003) 1052-1062
47. Salio M., Palmowski M.J., Atzberger A., Hermans I.F., and Cerundolo V. CpG-matured murine plasmacytoid dendritic cells are capable of in vivo priming of functional CD8 T cell responses to endogenous but not exogenous antigens. J. Exp. Med. 199 (2004) 567-579
48. Savina A., Jancic C., Hugues S., Guermonprez P., Vargas P., Moura I.C., Lennon-Dumenil A.M., Seabra M.C., Raposo G., and Amigorena S. NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells. Cell 126 (2006) 205-218
49. + T-cell responses in vivo after viral stimulation. Blood 104 (2004) 1808-1815
50. Schnurr M., Chen Q., Shin A., Chen W., Toy T., Jenderek C., Green S., Miloradovic L., Drane D., Davis I.D., et al. Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery. Blood 105 (2005) 2465-2472
51. Schwartz O., Riviere Y., Heard J.M., and Danos O. Reduced cell surface expression of processed human immunodeficiency virus type 1 envelope glycoprotein in the presence of Nef. J. Virol. 67 (1993) 3274-3280
52. Seifert U., Maranon C., Shmueli A., Desoutter J.F., Wesoloski L., Janek K., Henklein P., Diescher S., Andrieu M., de la Salle H., et al. An essential role for tripeptidyl peptidase in the generation of an MHC class I epitope. Nat. Immunol. 4 (2003) 375-379
53. Shortman K., and Heath W.R. Immunity or tolerance? That is the question for dendritic cells. Nat. Immunol. 2 (2001) 988-989
54. Siegal F., Kadowaki N., Shodell M., Fitzgerald-Bocarsly P., Shah K., Ho S., Antonenko S., and Liu Y. The nature of the principal type 1 interferon-producing cells in human blood. Science 284 (1999) 1835-1837
55. Sol-Foulon N., Esnault C., Percherancier Y., Porrot F., Metais-Cunha P., Bachelerie F., and Schwartz O. The effects of HIV-1 Nef on CD4 surface expression and viral infectivity in lymphoid cells are independent of rafts. J. Biol. Chem. 279 (2004) 31398-31408
56. + T cell populations lacking helper function. Nat. Immunol. 6 (2005) 163-170
57. Steinman R.M., Hawiger D., and Nussenzweig M.C. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21 (2003) 685-711
58. Tang Q., and Bluestone J.A. Plasmacytoid DCs and T(reg) cells: casual acquaintance or monogamous relationship?. Nat. Immunol. 7 (2006) 551-553
59. Trinchieri G., and Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat. Rev. Immunol. 7 (2007) 179-190
60. Trombetta E.S., Ebersold M., Garrett W., Pypaert M., and Mellman I. Activation of lysosomal function during dendritic cell maturation. Science 299 (2003) 1400-1403
61. + dendritic cells during allergen challenge abrogates the characteristic features of asthma. J. Exp. Med. 201 (2005) 981-991
62. Zhang J., Raper A., Sugita N., Hingorani R., Salio M., Palmowski M.J., Cerundolo V., and Crocker P.R. Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors. Blood 107 (2006) 3600-3608